Search research articles
Contact Us
Filters
Showing results (81-90 of 193) with videos related to
Page
of 20
Sort By:
NPJ Breast Cancer
|
August 11, 2017
Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
Brock Schroeder, Yi Zhang, Olle Stål, et al.
International Journal of Cancer
|
October 13, 2023
Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database
Hope S Rugo, Xianchen Liu, Benjamin Li, et al.
Journal of Medical Economics
|
August 1, 2019
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
Alison Stopeck, Adam Brufsky, Lisa Kennedy, et al.
Cancers
|
November 14, 2023
Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
The Oncologist
|
July 24, 2023
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
Hope S Rugo, Xianchen Liu, Benjamin Li, et al.
Future Oncology (London, England)
|
March 31, 2025
Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
International Journal of Clinical and Experimental Pathology
|
February 4, 2010
Biomarker profile in breast carcinomas presenting with bone metastasis
Olga L Bohn, Irem Nasir, Adam Brufsky, et al.
The Breast Journal
|
April 3, 2014
Metastasis of breast carcinoma to the maxillary sinus
José Pablo Leone, Saveri Bhattacharya, Mark A Socinski, et al.
Future Oncology (London, England)
|
March 27, 2024
Treatment outcomes in older patients with metastatic breast cancer receiving palbociclib plus an aromatase inhibitor: a plain language summary
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
Frontiers in Oncology
|
October 16, 2023
Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 193) with videos related to
Sort By:
Page
of 20
NPJ Breast Cancer
|
August 11, 2017
Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
Brock Schroeder, Yi Zhang, Olle Stål, et al.
International Journal of Cancer
|
October 13, 2023
Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database
Hope S Rugo, Xianchen Liu, Benjamin Li, et al.
Journal of Medical Economics
|
August 1, 2019
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
Alison Stopeck, Adam Brufsky, Lisa Kennedy, et al.
Cancers
|
November 14, 2023
Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
The Oncologist
|
July 24, 2023
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
Hope S Rugo, Xianchen Liu, Benjamin Li, et al.
Future Oncology (London, England)
|
March 31, 2025
Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
International Journal of Clinical and Experimental Pathology
|
February 4, 2010
Biomarker profile in breast carcinomas presenting with bone metastasis
Olga L Bohn, Irem Nasir, Adam Brufsky, et al.
The Breast Journal
|
April 3, 2014
Metastasis of breast carcinoma to the maxillary sinus
José Pablo Leone, Saveri Bhattacharya, Mark A Socinski, et al.
Future Oncology (London, England)
|
March 27, 2024
Treatment outcomes in older patients with metastatic breast cancer receiving palbociclib plus an aromatase inhibitor: a plain language summary
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
Frontiers in Oncology
|
October 16, 2023
Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older
Adam Brufsky, Xianchen Liu, Benjamin Li, et al.
Page
of 20